Pfizer CEO Agrees to Lower Drug Prices for Medicaid
Source: Pfizer CEO Albert Bourla agrees to lower prescription drug prices for Medicaid in deal with president, participate in TrumpRx (2025-09-30)
Albert Bourla, CEO of Pfizer, has agreed to reduce prescription drug prices for Medicaid as part of a new deal with the president. The agreement also involves Pfizer participating in the TrumpRx initiative, aiming to make medications more affordable for Medicaid recipients. This move marks a significant step in efforts to lower healthcare costs and increase drug accessibility. The deal highlights ongoing negotiations between pharmaceutical companies and the government to address rising drug prices and improve public health outcomes.